在重症综合免疫缺陷分子诊断中的目标下一代测序
Evangelos Bakaros1, Styliani Sarrou1, Antonios Gkantaras2
1Department of Immunology and Histocompatibility, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.
Medicina (Kaunas, Lithuania)
|September 27, 2025
概括
严重联合免疫缺陷 (SCID) 是一组致命的遗传性疾病. 使用下一代测序 (NGS) 快速诊断对于及时治疗和改善SCID婴儿的治疗结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 严重联合免疫缺陷 (SCID) 包括罕见的,危及生命的单一性疾病.
- 迟到的SCID诊断会对存活率和造血干细胞移植 (HSCT) 成功产生负面影响.
研究的目的:
- 实施下一代测序 (NGS) 试验,以快速准确的SCID诊断.
- 在怀疑SCID的婴儿中识别遗传缺陷.
主要方法:
- 开发了一个有针对性的NGS小组,分析了30个SCID相关基因.
- 将NGS小组应用于三名呈现SCID症状的希腊婴儿.
主要成果:
- 在所有三位患者中确定了SCID相关基因的独特病原体变异.
- 患者1:异合的ADA变种. 患者2:DCLRE1C变异导致阿尔特米斯缺乏症. 患者3:IL2RG变异与X相关的SCID相关.
- 通过桑格测序证实了所有变体.
结论:
- 针对性的NGS试验成功地在所有测试的婴儿中建立了SCID的分子诊断.
- 强调NGS对迅速和精确的SCID诊断的实用性,这对于早期干预至关重要.
相关概念视频
Immunodeficiency Diseases
2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.0K
Next-generation Sequencing
97.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.8K


